11/09/2021

T. Rowe Price Forms Exclusive Partnership with UBS

The Strategy is one of the most established strategies dedicated to investing in health sciences companies with US$19.3 billion asset under management1 and a long track record dating back to its inception in 1995.

11/08/2021

The future of wealth management

With its fast-growing middle-class population, South-east Asia is home to a large number of emerging affluent.

11/02/2021

StanChart Profits Surge

We delivered a return to top-line growth in the third quarter and achieved further progress against our strategic priorities